202305850
Case History and Clinical Findings
CHIEF COMPLAINTS:
C/O SHIVERING SINCE MORNING C/O SWEATING SINCE MORNING
HOPI:
PATIENT
WAS APPARENTLY ASYMPTOMATIC 4 MONTHS BACK THEN SHE HAD SWEATING, BREIF LOSS OF CONSCIOUSNESS AND WENT TO
LOCAL HOSPITAL DIAGNOSED WITH HYPOGLYCEMIC
EPISODE. SHE HAD SIMILAR TWO EPISODES IN THE MIDNIGHT 1 DAY BACK. SHE WAS BROUGHT TO OUR HOSPITAL FOR
FURTHER MANAGEMENT.
PAST HISTORY:
H/O
SIMILAR EPISODE IN THE PAST 4 MONTHS BACK. K/C/O
DM SINCE 5 YEARS (ON GLIMI M1)
NOT
A K/C/O HTN, EPILEPSY, TB, ASTHMA, THYROID.
GENERAL EXAMINATION:
PATIENT IS
CONSCIOUS, COHERENT AND COOPERATIVE.
NO
PALLOR, ICTERUS, CYANOSIS, CLUBBING, LYMPHADENOPATHY. EDEMA OF FEET PRESENT.
VITALS
AT ADMISSION: TEMPERATURE: AFEBRILE PR:112BPM
RR:24CPM BP:180/110MMHG SPO2:100% GRBS:38MG/DL SYSTEMIC
EXAMINATION:
CVS:
S1 S2 PRESENT NO MURMURS RESPIRATORY SYSTEM:
NORAML
VESICULAR BREATH SOUNDS HEARD PER
ABDOMEN:
SHAPE
OF ABDOMEN : OBESE SOFT AND
NONTENDER
CNS: NFND
VITALS
AT DISCHARGE : BP:140/80MMHG PR:82BPM
GRBS:90MMHG
COURSE IN THE
HOSPITAL:-
47YEAR
OLD FEMALE, KNOWN DIABETIC SINCE 5YEARS IS ON TAB.GLIMI M1 1/2TAB OD, WITH RECURRENT HYPOGLYCEMIC EPISODES
PRESENTED TO OUR CASUALTY FOR FURTHER
MANAGEMTNENT. ON EVALUATION, HER METABOLLIC PROFILE SHOWED GRBS- 38MG/DL. INJ. 25% DEXTROSE IV BOLUS AND
WAS MAINTAINED AT INJ.25% DEXTROSE IV @10ML/HR.
ON
NEXT DAY INJ. 25%DEXTROSE WAS TAPERED DOWN TO 2.5ML/HR.LATER WAS CONVERTED TO PLENTY OF ORAL FLUIDS
GASTROENTEROLOGY
OPINION WAS TAKEN FOR HETEROECHOIC LESION IN LIVER SEGMENT IV A AND ADVISED FOR AFP,CEA AND TRIPHASIC CT SCAN AND
BIOPSY UROLOGY OPINION WAS TAKEN FOR B/L HYDROURETRONEPHROSIS AND WAS ADVISED
NON CONTRAST CT-KUB.
OPTHALMOLOGY
OPINION WAS TAKEN FOR HYPERTENSIVE AND DIABETIC RETINOPATHY AND NO CHANGES WERE SEEN
GYNECOLOGY OPINION WAS TAKEN FOR B/L
HYDROURETRONEPHROSIS AND TRANSVAGINAL
SONOGRAPHY WAS DONE AND NO ABNORMALITY DETECTED PATIENT IS BEING DISCHARGED IN HEMODYNAMICALLY STABLE
CONDITION.
Investigation
HB-8.6-7.4-7.1-7.8GM/DL
TLC-7,900-6,600-6,400-7,000CELLS/CUMM PLT-2.52-2.47-2.27-2.18LAKHS
2D ECHO:
MILD
MR+; TRIVIAL TR+; NO MR NO RWMA. NO
AS/MS
GOOD
LV SYSTOLIC FUNCTION DIASTOLIC
DYSFUNCTION +; NO PAH/PE REVIEW 2D
ECHO: 8/2/23
NO RWMA MILD
LVH+
MILD
AR+; TRIVIAL TR+/MR+ SCLEROTIC AV,
NO AS/MS EF=58; RVSP:35MMHG
GOOD
LV SYSTOLIC FUNCTION DIASTOLIC
DYSFUNCTION+, NO PAH/PE IVC SIZE
(0.81CMS) COLLAPSING
USG:6/2/23 RT.KIDNEY-11*5.2CM
LEFT KIDNEY-
10.8*5CM
E/O
HETEROECHOIC LESION IN THE LIVER SEGMENT 4 A , LIKELY MALIGNANT ETIOLOGY B/L HYDROURETERO NEPHROSIS
RIGHT COMPLEX
CYST IN KIDNEY.
INTERNAL
ECHOES SEEN WITH BLADDER WALL THICKENING ?CYSTITIS CORRELATE WITH CUE.
REVIEW USG
I/V/O CORTICAL THICKNESS:
IMPRESSION:
B/L
MODERATE HYDROURETERONEPHROSIS SIGNIFIACNT
PVR
TRANSVAGINALSONOGRAPHY 11/2/23 UTERUS:-6.3*2.6CM
ET-2-3MM MYOMETRIUM-NORMAL
OVARIES-NOT
VISUALISED POUCH OF DUGLUS-NIL
AFP-1.50 CEA-1.86
Treatment Given(Enter only
Generic Name)
INJ
25% DEXTROSE IV @15 ML/HR (INCREASE OR DECREASE TO MAINTAIN GRBS 200- 250MG/DL)
IV
FLUIDS 1 NS AND 1 RL @ 125 ML/HR TAB
CILNIDIPINE 10 MG PO/OD
SYP
CREMAFFIN PLUS PO/H//S 10 ML WITHHOLD
OHS
Advice at Discharge
1. TAKE PLENTY OF ORAL FLUIDS
2. TAB CILNIDIPINE 10 MG PO OD AT 8AM
3. TAB OROFER XT PO/OD AT 2PM FOR 1 MONTH
3. SYP CREMAFFIN PLUS PO/HS 10 ML AT 9PM BEDTIME
4. WITHHOLD ORALHYPOGLYCEMIC DRUGS
Comments
Post a Comment